ALX Oncology Holdings Inc.
ALXO
$0.55
-$0.01-1.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -134.85M | -151.16M | -171.44M | -166.20M | -160.81M |
| Total Depreciation and Amortization | 872.00K | 865.00K | 1.07M | 837.00K | 836.00K |
| Total Amortization of Deferred Charges | 265.00K | 260.00K | 257.00K | 253.00K | 250.00K |
| Total Other Non-Cash Items | 24.23M | 23.83M | 22.68M | 21.45M | 21.06M |
| Change in Net Operating Assets | -12.43M | -3.34M | 12.11M | 3.19M | 8.30M |
| Cash from Operations | -121.91M | -129.54M | -135.33M | -140.47M | -130.36M |
| Capital Expenditure | -447.00K | -535.00K | 917.00K | -732.00K | -1.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.70M | 36.94M | 22.61M | 29.57M | 45.93M |
| Cash from Investing | 86.26M | 36.41M | 23.53M | 28.84M | 44.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -827.00K | -814.00K | -567.00K | -456.00K | -388.00K |
| Issuance of Common Stock | 31.58M | 95.16M | 95.16M | 64.32M | 64.08M |
| Repurchase of Common Stock | -29.59M | -29.59M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.66M | 24.90M | -5.30M | -1.38M | -4.40M |
| Cash from Financing | 30.82M | 89.66M | 89.29M | 62.48M | 59.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.84M | -3.48M | -22.51M | -49.15M | -26.42M |